Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 52 Pancreatic Neoplasms 34 Colonic Neoplasms 20 Carcinoma, Hepatocellular 20 Esophageal Neoplasms 15 Neoplasms 14 Breast Neoplasms 12 Gastrointestinal Neoplasms 11 Stomach Neoplasms 10 Liver Neoplasms 10 Rectal Neoplasms 9 Lung Neoplasms 8 Head and Neck Neoplasms 7 Fibrosis 6 Biliary Tract Neoplasms 5 Ovarian Neoplasms 4 Neoplastic Cells, Circulating 4 Neoplasm, Residual 4 Neoplasm Metastasis 4 Gastrointestinal Stromal Tumors 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Pancreatic Cyst 3 Melanoma 3 Cholangiocarcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Cachexia 3 Sarcoma 2 Prostatic Neoplasms 2 Pancreatic Diseases 2

Interventions

Endoscopy 15 Endoscopy, Digestive System 13 Biopsy 11 Endoscopic Mucosal Resection 8 Specimen Handling 7 Radiofrequency Ablation 7 Esomeprazole 7 Gastroscopy 6 Proflavine 4 Omeprazole 4 Aspirin 4 Narrow Band Imaging 3 Diagnostic Imaging 3 Breath Tests 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Dexlansoprazole 2 Cryotherapy 2 Cryosurgery 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 plecanatide 1 omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × Blood Specimen Collection × Gastrointestinal × Clear all

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡